NEW YORK, Jan. 17, 2023 /PRNewswire/ -- Actinium Pharmaceuticals, Inc. (NYSEAMERICAN:ATNM) (Actinium or the Company), a leader in the development of targeted radiotherapies, today announced that the Company's management team will participate in a fireside chat on Thursday, January 19, 2023 at 10:30 AM EST at the 3rd Annual B. Riley Securities Oncology Conference. The webcast of the presentation will be accessible on the event's website at https://brileyoncology22.sequireevents.com/ and on the investor relations page of Actinium's website https://ir.actiniumpharma.com/. A replay of the presentation will be available on the day of the fireside chat through the same links.
Read more at prnewswire.comActinium Pharmaceuticals, Inc. to Present at the 3rd Annual B. Riley Securities Oncology Conference
PR Newswire - Press Release
All information and data in this article is solely for informational purposes. For more information please view the Barchart Disclosure Policy here
/Technology%20abstract%20by%20TU%20IS%20via%20iStock.jpg)
/Quantum%20Computing/A%20concept%20image%20with%20a%20brain%20on%20top%20of%20a%20blue%20circuit%20board_%20Image%20by%20Gorodenkoff%20via%20Shutterstock_.jpg)